Finding genetic causes of inherited hemolytic anemia
Part of Blood & lymphatic clinical trials.
This research study helps doctors identify the genetic reason why some people have hemolytic anemia (a condition where red blood cells break down too quickly). Researchers will study patients with this condition and their family members to understand the underlying cause and potentially improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hereditary hemolytic anemia (an inherited condition where red blood cells break down faster than normal)
- Your diagnosis is confirmed by blood tests including a complete blood count, reticulocyte count, and blood smear review
- The genetic cause of your anemia has not yet been identified or is difficult to determine
- You may be a parent or grandparent of a child with this condition and willing to participate
- Your anemia is inherited (genetic), not acquired from infection, medication, or another non-genetic cause
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults who are in the hospital with acquired hemolytic anemia, a condition where the body destroys red blood cells too quickly. The goal is to understand this condition better and improve care for patients like you.
This study looks at new ways to use routine blood test results to help diagnose hereditary spherocytosis, a condition where red blood cells are fragile. The goal is to make diagnosis easier and more accurate for children.
This study is a registry that collects medical and lab information from people with congenital dyserythropoietic anemia (CDA), a lifelong type of anemia that can cause jaundice. It helps doctors better understand the condition and its causes, including in families where it runs.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This trial studies the genes of people with a rare type of inherited anemia called congenital sideroblastic anemia, where the body has trouble making healthy red blood cells. It aims to find new genetic causes by looking at genes involved with the cell's energy centers (mitochondria).
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
Hear when a new Hemolytic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.